gms | german medical science

Meeting Abstract (OP256)

A randomized trial of surgery and radiotherapy versus radiosurgery alone in the treatment of single metastasis to the brain

Muacevic A, Wowra B, Kreth FW, Tonn JC

[Abstract] [Full Text] [XML]

Meeting Abstract (OP257)

The regulatory role of transforming growth factor-ß2 in malignant glioma invasion by modulation of extracellular matrix

Hau P, Arslan F, Dörfelt A, Bosserhoff A, Bogdahn U

[Abstract] [Full Text] [XML]

Meeting Abstract (OP258)

Imatinib (STI 571)/ plus Hydroxyurea: Safety and efficacy in pre-treated, progressive Glioblastoma Multiforme (GBM) patients (pts) – an update on the initial 30 pts

Dresemann G

[Abstract] [Full Text] [XML]

Meeting Abstract (OP259)

Imatinib plus Hydroxyurea in Pretreated Non-Progressive Glioblastoma (GBM) – a Single Center Phase II Study

Dresemann G, Hosius C, Weinkauf B, Nikoloya Z, Letvak L

[Abstract] [Full Text] [XML]

Meeting Abstract (OP260)

Re-irradiation of Recurrent Astrocytomas withFractionated Stereotacic Radiotherapy (FSRT)

Combs S, Thilmann C, Edler L, Debus J, Schulz-Ertner D

[Abstract] [Full Text] [XML]

Meeting Abstract (PO261)

Reverse engineering of extended regulatory networks in human gliomas

Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI

[Abstract] [Full Text] [XML]

Meeting Abstract (PO262)

A high-resolution map of the human glioma genome

Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI

[Abstract] [Full Text] [XML]

Meeting Abstract (PO263)

TGF-beta and metalloproteinases suppress NKG2D ligand surface expression differentially on malignant glioma cells

Eisele G, Wischhusen J, Friese M, Mittelbronn M, Meyermann R, Steinle A, Wick W, Weller M

[Abstract] [Full Text] [XML]

Meeting Abstract (PO264)

Targeted tumor therapy with the compound AP 12009 directed against TGF-b2 in high-grade glioma patients: Results of a phase II study

Hau P, Bogdahn U, Koch D, Pichler J, Mehdorn M, Meixensberger J, Schackert G, Grisold W, Stockhammer G, Schneider T, Weller M, Wassmann H

[Abstract] [Full Text] [XML]

Meeting Abstract (PO265)

Continuous low dose chemotherapy in combination with a COX-II inhibitor as an antiangiogenic approach in patients with glioblastoma multiforme

Tüttenberg J, Grobholz R, Korn T, Wenz F, Erber R, Vajkoczy P

[Abstract] [Full Text] [XML]

Meeting Abstract (PO266)

Identification of regeneration and tolerance factor (RTF) as a novel mediator of glioblastoma-associated immunosuppression

Roth P, Aulwurm S, Meyermann R, Beaman K, Weller M, Wischhusen J

[Abstract] [Full Text] [XML]

Meeting Abstract (PO267)

Intracranial arteries as organs at risk in intensity-modulated radiotherapy for skull base tumors

Nieder C, Grosu AL, Astner S, Busch R, Kneschaurek P, Molls M

[Abstract] [Full Text] [XML]

Meeting Abstract (PO268)

Long-term survivors with glioblastoma multiforme after concurrent Temozolomide (TMZ) and radiotherapy

Micke O, Schäfer U, Schüller P, Willich N

[Abstract] [Full Text] [XML]

Meeting Abstract (PO269)

Bortezomib sensitizes primary human esthesioneuroblastoma cells for TRAIL-induced apoptosis

Koschny R, Holland H, Sykora J, Sprick MR, Haas TL, Ganten TM, Krupp W, Bauer M, Ahnert P, Meixensberger J, Walczak H

[Abstract] [Full Text] [XML]

Meeting Abstract (PO270)

STI571 (Imatinib, Glivec) affects the migratory behavior of human glioma cells in vitro

Möhlenbruch M, Möhlenbruch M, Horn S, Herr M, Schollmeyer A, Perneczky A, Hopf N

[Abstract] [Full Text] [XML]

Meeting Abstract (PO271)

Combined Regimen of Temozolomide and liposomal pegylated Doxorubicin in Glioblastoma – Toxicity and Efficacy

Hau P, Jauch T, Baumgart U, Beier C, Beier D, Gänßbauer S, Glas M, Hirschmann B, Koch H, Wismeth C, Steinbrecher A, Bogdahn U

[Abstract] [Full Text] [XML]

Meeting Abstract (PO272)

Cranial Radiation Therapy Induces Acute Cognitive Impairments in Patients with Brain Tumors Only

Welzel G, Fleckenstein K, Thönnessen D, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai S, Wenz F

[Abstract] [Full Text] [XML]

Meeting Abstract (PO273)

Bortezomib sensitizes primary human esthesioneuroblastoma cells for TRAIL-induced apoptosis

Koschny R, Holland H, Sykora J, Sprick MR, Haas TL, Ganten TM, Krupp W, Bauer M, Meixensberger J, Walczak H

[Abstract] [Full Text] [XML]

Meeting Abstract (PO274)

Surviving glioblastoma for more than 5 years: the patients´ perspective

Steinbach J, Blaicher HP, Herrlinger U, Wick W, Nägele T, Meyermann R, Tatagiba M, Bamberg M, Dichgans J, Karnath HO, Weller M

[Abstract] [Full Text] [XML]

Meeting Abstract (PO275)

Therapy of medulloblastoma in adults (NOA 07) – a multicentric, population-based pilot study

Beier D, Bogdahn U, Hau P, Grauer O, Weller M, Kortmann RD, Rutkowski S, Wagner S, Engel C, Pietsch T, Warmuth-Metz M, Hofer S

[Abstract] [Full Text] [XML]

Meeting Abstract (PO276)

Radiochemotherapie bei rezidivierten vorbestrahlten malignen Hirntumoren

Schäfer U, Micke O

[Abstract] [Full Text] [XML]

Meeting Abstract (PO277)

Experimental Models of monocytic infiltration into gliomas

Strik H, Hülper P, Hemmerlein B, Erdlenbruch B, Meier J, Kowalewski A, Gold R, Bähr M

[Abstract] [Full Text] [XML]

Meeting Abstract (PO278)

Postoperative radiotherapy of glioblastoma multiforme: analysis und critical assessment of different predictive factors

Piroth MD, Gagel B, Pinkawa M, Stanzel S, Eble MJ

[Abstract] [Full Text] [XML]

Meeting Abstract (PO279)

Clicinal results and results of quality assurance of intraoperative radiotherapy (IORT) in 72 brain tumor patients: Implications of a "learning curve"

Schüller P, Palkovic S, Schröder J, Schuck A, Micke O, Wassmann H, Willich N

[Abstract] [Full Text] [XML]

Meeting Abstract (PO280)

Neoadjuvant Therapy with Temozolomide and 13-cis-Retinoic Acid in High Grade Glioma – a Phase II-Study

Hau P, Hirschmann B, Jauch T, Baumgart U, Beier C, Beier D, Gänßbauer S, Glas M, Koch H, Wismeth C, Steinbrecher A, Bogdahn U

[Abstract] [Full Text] [XML]